Wayne Pisano insider trades
Open-market stock purchases and sales by Wayne Pisano, Director at Oncolytics Biotech Inc, from SEC Form 4 filings since Jul 19, 2018.
Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -47%.
Open-market stock purchases and sales by Wayne Pisano, Director at Oncolytics Biotech Inc, from SEC Form 4 filings since Jul 19, 2018.
Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -47%.